Guanfacine (Tenex) safety and efficacy is being assessed in the treatment of Tourette's Syndrome (TS) and Attention Deficit Hyperactivity Disorder (ADHD) occurring separately or as comorbid conditions.
Showing the most recent 10 out of 312 publications